-
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals
Study
EGAS50000000715
-
Whole-genome cfDNA TAPS sequencing data from 91 people with various types of cancer and from non-cancer controls
Dataset
EGAD50000000996
-
cfDNA whole-genome TAPS data for cancer detection DAC
Dac
EGAC50000000440
-
Transcriptomics for the ALTTO study
Dataset
EGAD50000000746
-
WES in muscle-invasive bladder cancer (MIBC) treated with durvalumab plus olaparib in the neoadjuvant setting: NEODURVARIB trial
Study
EGAS50000000791
-
Uncovering Principles of Adaptive Regulation in Cancer Resistance Through Deep Evolutionary Profiling
Study
phs003851
-
Melanoma Genome Sequencing Project
Study
phs000452
-
Patient-derived xenograft models of head and neck cancers
Dac
EGAC50000000502
-
Subclonal diversification of primary breast cancer
Dataset
EGAD00001000898
-
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study
EGAS00001006007
-
Resident memory CD8 T cell in human lung cancer
Study
EGAS00001004707
-
RNA sequencing of PTCL-NOS
Study
EGAS00001005015
-
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Study
EGAS00001003115
-
Genomic profiling of patient-derived xenografts and organoids in prostate cancer
Study
EGAS00001004673
-
Activation of IL7RA signalling in human B-lymphoid precursors induces pre-leukemia
Study
EGAS00001003979
-
Transcriptomic profiling of patient-derived xenografts and organoids in prostate cancer
Study
EGAS00001004675
-
A machine learning classifier for DNA repair defects using plasma DNA
Study
EGAS00001007006
-
Preliminary Results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT 2) Study
Study
EGAS00001004964
-
Single cell RNAseq of PBMC from bladder cancer patients
Study
EGAS00001004458
-
Whole exome sequencing from small cell lung cancer patients
Study
EGAS00001005087
-
Genomic landscape of DS-ALL
Study
EGAS00001006600
-
DNA polymerase and mismatch repair deficient cancers exert distinct genome-wide microsatellite signatures 2
Study
EGAS00001004816
-
Expression profiles and genetic makeup of metastases of a cancer of unknown primary.
Study
EGAS00001004059
-
Degradation of Cyclin K/CDK12 is a druggable vulnerability of colorectal cancer (H012)
Study
EGAS00001004517
-
Extreme intratumor heterogeneity and driver evolution in mismatch repair deficient gastro-esophageal cancer
Study
EGAS00001003434